Product Information
DROSPIRENONE-EE 3-0.02 MG TAB is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1895 per EA under NDC 31722093432. Its NADAC has been published 299 times since Dec 2, 2020.
FDA first approved this application on Mar 22, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722093432
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA211944FDA Approved
3/22/2019
TE Code
AB
On Market Since
3/22/2019
Price Statistics
The NADAC for DROSPIRENONE-EE 3-0.02 MG TAB has been published 299 times since Dec 2, 2020, and over the history we have for it it has declined 53.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1895 per EA |
|---|---|
| All-time high | $0.4077 (Jan 12, 2022) |
| All-time low | $0.1278 (Nov 20, 2024) |
| 52-week high | $0.1933 |
| 52-week low | $0.1538 |
| Median price | $0.2629 |
| Average price | $0.2567 |
| Largest weekly change | -32.1% (Nov 20, 2024) |
| Weeks tracked | 299 |
| Tracking since | Dec 2, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DROSPIRENONE-EE 3-0.02 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DROSPIRENONE-EE 3-0.02 MG TAB, manufactured by Camber Pharmaceuticals Inc., is $0.1895 per EA (NDC 31722093432), effective Aug 19, 2026.
How has the price of DROSPIRENONE-EE 3-0.02 MG TAB changed over time?
Over the history we have for it, the NADAC for DROSPIRENONE-EE 3-0.02 MG TAB has declined 53.3%. It has been tracked across 299 weekly CMS publications since Dec 2, 2020.
What are the highest and lowest recorded NADAC prices for DROSPIRENONE-EE 3-0.02 MG TAB?
Since Dec 2, 2020, the NADAC for DROSPIRENONE-EE 3-0.02 MG TAB has ranged from a low of $0.1278 (Nov 20, 2024) to a high of $0.4077 (Jan 12, 2022), with a median of $0.2629 per EA.
Are there cheaper alternatives to DROSPIRENONE-EE 3-0.02 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DROSPIRENONE-EE 3-0.02 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures DROSPIRENONE-EE 3-0.02 MG TAB?
DROSPIRENONE-EE 3-0.02 MG TAB (NDC 31722093432) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.